To assess whether the infections suffered by SLT patients are consistent with an impairment in IL-17 immunity, we devise a scoring system based on the infection-related components of the Hyper-IgE syndrome diagnostic criteria, and apply this to SLT patients and controls (Supplemental Table 5)31. This evidence concerns the gene IL17A and infection.